A 28-year-old man with childhood-onset absence seizures (CAE) and a 19-year-old woman with juvenile myoclonic epilepsy (JME) both present to the neurology clinic. Which clinical or EEG feature best distinguishes juvenile myoclonic epilepsy from childhood absence epilepsy?

Explanation

## Distinguishing Juvenile Myoclonic Epilepsy from Childhood Absence Epilepsy ### Clinical and EEG Comparison **Key Point:** While both CAE and JME are primary generalized epilepsies with generalized spike-and-wave on EEG, **myoclonic jerks** — especially morning jerks triggered by sleep deprivation or photic stimulation — are the pathognomonic distinguishing feature of JME. ### Comparative Table | Feature | Childhood Absence Epilepsy (CAE) | Juvenile Myoclonic Epilepsy (JME) | | --- | --- | --- | | **Age of onset** | 3–8 years (peak 5–7) | 8–20 years (peak 12–18) | | **Seizure types** | Absence only (initially) | Myoclonic + absence + GTCS | | **Myoclonic jerks** | Absent | Present (morning, sleep deprivation) | | **GTCS** | Develops in ~30% later | Develops in ~80% | | **EEG: spike-wave** | 3 Hz (regular) | 4–6 Hz (often polyspike-wave) | | **Photosensitivity** | ~30% | ~30–40% | | **Drug of choice** | Ethosuximide | Valproate (or levetiracetam) | | **Prognosis** | ~70% remission | Lifelong; requires long-term therapy | | **Gender** | Female predominance (2:1) | Female predominance (2:1) | ### Why Option 1 Is Correct **High-Yield:** Myoclonic jerks — brief, involuntary jerking movements of the arms and shoulders — are the **clinical hallmark of JME**. They occur characteristically in the morning upon waking, are exacerbated by sleep deprivation, fatigue, stress, and photic stimulation, and are often the first symptom. This seizure type is **absent in CAE**, making it the single best discriminator. **Mnemonic:** **JME = "Jump in the Morning"** — myoclonic jerks on waking are pathognomonic. ### Why the Other Options Are Misleading **Clinical Pearl:** Generalized 3 Hz spike-and-wave (option 1) is present in *both* CAE and JME. While CAE typically shows regular 3 Hz discharges and JME often shows faster (4–6 Hz) polyspike-and-wave, this distinction requires EEG expertise and is not as clinically obvious as the presence of myoclonic jerks. Seizure onset before age 10 (option 3) is common in CAE (peak 5–7 years) but JME typically begins in adolescence (8–20 years, peak 12–18). However, there is overlap, and this is less specific than the seizure semiology. Ethosuximide response (option 4) is characteristic of CAE (first-line drug) but is **ineffective in JME** — in fact, ethosuximide may worsen myoclonic seizures. Valproate is the drug of choice for JME. However, this is a pharmacological rather than clinical discriminator and requires knowledge of treatment algorithms. ### Diagnostic Confirmation **Key Point:** - **CAE:** Absence seizures (staring spells, 10–20 sec), normal interictal EEG with 3 Hz spike-wave during seizure, excellent prognosis with ethosuximide. - **JME:** Myoclonic jerks + absences + generalized tonic-clonic seizures, EEG with 4–6 Hz polyspike-wave, lifelong condition requiring valproate or levetiracetam. **Warning:** Do not confuse the two — treating JME with ethosuximide alone will fail to control myoclonic and tonic-clonic seizures and may worsen myoclonia. [cite:Harrison 21e Ch 369; Robbins 10e Ch 28]